Observational analysis shows GuanCEST signal intensity reductions correlate with Parkinson's severity, suggesting a biomarker for targeted treatments.
Motivation: Creatine (Cr) is a potential biomarker for Parkinson's disease (PD), yet the relationship between PD severity and Cr levels in subcortical brain regions remains unclear. Goal(s): To investigate the relationship between Cr-weighted CEST signals in subcortical regions and PD severity. Approach: Guanidino chemical exchange saturation transfer (GuanCEST) MRI is a Cr-weighted metric. Reductions of GuanCEST intensity in thalamic subregions in PD patients versus healthy controls were correlated with disease duration and severity. Results: Greater reduction in GuanCEST levels was observed with increasing PD severity, particularly in thalamic subregions. This is tentatively interpreted to be due to lower Cr levels in these regions. Impact: Reductions in Cr-weighted GuanCEST MRI signal in several sensitive brain regions correlated to Parkinson's severity, based on motor system scores, suggesting a potential biomarker to help identify responsive cohorts for targeted treatments and trial design.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: